HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Gene replacement therapy restores RCBTB1 expression and cilium length in patient-derived retinal pigment epithelium.

Abstract
Biallelic mutations in the RCBTB1 gene cause retinal dystrophy. Here, we characterized the effects of RCBTB1 gene deficiency in retinal pigment epithelial (RPE) cells derived from a patient with RCBTB1-associated retinopathy and restored RCBTB1 expression in these cells using adeno-associated viral (AAV) vectors. Induced pluripotent stem cells derived from a patient with compound heterozygous RCBTB1 mutations (c.170delG and c.707delA) and healthy control subjects were differentiated into RPE cells. RPE cells were treated with AAV vectors carrying a RCBTB1 transgene. Patient-derived RPE cells showed reduced expression of RCBTB1. Expression of NFE2L2 showed a non-significant reduction in patient RPE cells compared with controls, while expression of its target genes (RXRA, IDH1 and SLC25A25) was significantly reduced. Trans-epithelial electrical resistance, surface microvillus densities and primary cilium lengths were reduced in patient-derived RPE cells, compared with controls. Treatment of patient RPE with AAV vectors significantly increased RCBTB1, NFE2L2 and RXRA expression and cilium lengths. Our study provides the first report examining the phenotype of RPE cells derived from a patient with RCBTB1-associated retinopathy. Furthermore, treatment of patient-derived RPE with AAV-RCBTB1 vectors corrected deficits in gene expression and RPE ultrastructure, supporting the use of gene replacement therapy for treating this inherited retinal disease.
AuthorsZhiqin Huang, Dan Zhang, Shang-Chih Chen, Luke Jennings, Livia S Carvalho, Sue Fletcher, Fred K Chen, Samuel McLenachan
JournalJournal of cellular and molecular medicine (J Cell Mol Med) Vol. 25 Issue 21 Pg. 10020-10027 (11 2021) ISSN: 1582-4934 [Electronic] England
PMID34617687 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© 2021 The Authors. Journal of Cellular and Molecular Medicine published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd.
Chemical References
  • Guanine Nucleotide Exchange Factors
  • RCBTB1 protein, human
Topics
  • Cell Differentiation
  • Cells, Cultured
  • Cilia (metabolism, ultrastructure)
  • Dependovirus (genetics)
  • Gene Expression
  • Genetic Therapy (methods)
  • Genetic Vectors (genetics)
  • Guanine Nucleotide Exchange Factors (genetics)
  • Humans
  • Induced Pluripotent Stem Cells (cytology, metabolism)
  • Retinal Dystrophies (genetics, therapy)
  • Retinal Pigment Epithelium (metabolism, ultrastructure)
  • Transduction, Genetic
  • Transgenes

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: